Additional file 1 of A multicountry study to establish rates for pregnancy and neonatal outcomes in low- and middle-income regions
Antonella N. Tullio(GlaxoSmithKline (United States)), Gaël Dos Santos(Universidade Federal de Campina Grande), Tirza De León, Juliana Caccavo(Hospital Donación Francisco Santojanni), Andrea Falaschi, Conrado Milani Coutinho(Leeds Teaching Hospitals NHS Trust), María Florencia Lución(Hospital General de Niños Ricardo Gutierrez), Alexandra Sierra Garcia(Clínica Santa María), Sri Wahyu Taher, Clara del Carmen Flores Acosta(Universidad Autónoma de Nuevo León), Sridevi Pallem(Enzo Life Sciences (United States)), Jesús Arnulfo Velásquez Penagos(Hospital Universitario de San Vicente Fundación), Jorge Pinto(University of Trás-os-Montes and Alto Douro), M.T. Rodriguez Brieschke(Hospital Donación Francisco Santojanni), Maria Fernanda Roa(Fundación Santa Fe de Bogotá), Khatija Ahmed(University of California, San Francisco), Lavitha Sivapatham(KPJ Ampang Puteri Specialist Hospital), Linda Aurpibul(Chiang Mai University), Khalequ Zaman(International Centre for Diarrhoeal Disease Research), Marisa Márcia Mussi‐Pinhata(Universidade de São Paulo), Ivonne Abadía de Regalado(Panama Canal Authority), Malahleha Moelo(Setshaba Research Centre), Agnes Akawung, Joon Hyung Kim(GlaxoSmithKline (United States)), Ángela Gentile(Universidad de Buenos Aires), Eduardo López-Medina, Camilo Enrique Rodriguez(Universidad de Los Andes), Christine Mui Fong Lee(Sarawak General Hospital), Thanyawee Puthanakit(Chulalongkorn University), Juan Nicolas Rodriguez Niño(Fundación Santa Fe de Bogotá), Jacinto Blass III V. Mantaring(Philippine General Hospital), Chenchit Pichailuck(Mahidol University), Ulises D’Andrea Nores(Instituto Médico Río Cuarto), Samantha Fry(Stellenbosch University), Juan Carlos Tinoco, Pablo Dieser(Instituto Médico Río Cuarto), Diana Andrea Arias Fernandez, Alexandre Vargas Schwarzbold(Universidade Federal de Santa Maria), Ouzama Henry(Dynavax Technologies (United States)), Bladimir Marin, Ruben Luca, Yongjia Pu(AbbVie (United States)), Osvaldo Reyes, Ruey Soon, Sheena Kotze, Emad Yanni(GlaxoSmithKline (United States)), Ik Hui Teo, Mara De Bernardi(Hospital Donación Francisco Santojanni), Emily Christine D’Silva, Ana Ceballos(Instituto Médico Río Cuarto)
Cited by 0
Related Papers
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women
|New England Journal of Medicine|2024|471
A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness
|International Journal of Infectious Diseases|2020|302
Birth Prevalence and Natural History of Congenital Cytomegalovirus Infection in a Highly Seroimmune Population
|Clinical Infectious Diseases|2009|276
Three Postpartum Antiretroviral Regimens to Prevent Intrapartum HIV Infection
|New England Journal of Medicine|2012|236